Scope
Reference
C379087
Description
This contract comprises two distinct phases. For phase 1 the Authority wishes to purchase service to bring the CPRD Safe Trusted Research Environment system out of MVP into Alpha, Beta and production phases by continually developing the product using agile methodology. Phase 2 will focus on service and Maintenance of the CPRD Safe Trusted Research Environment system. MHRA is looking to award one contract to one supplier, but reserves the right to award more than one contract to more than one supplier.
For the avoidance of doubt, any information provided to the MHRA in response to this RFI will be treated as confidential and non-binding. No contract will be awarded as a consequence of this RFI process, however, the MHRA may launch a procurement opportunity in the near future.
Responding to this RFI is not a prerequisite for participation in a subsequent procurement, nor does it give any advantage in that procurement. The MHRA would welcome responses to this RFI in order that the MHRA can build an understanding regarding the current and future provision of the project.
Total value (estimated)
- £7,500,000 excluding VAT
- £9,000,000 including VAT
Above the relevant threshold
Contract dates (estimated)
- 22 April 2026 to 22 April 2031
- 5 years, 1 day
Main procurement category
Services
CPV classifications
- 72000000 - IT services: consulting, software development, Internet and support
Contract locations
- UK - United Kingdom
Engagement
Engagement deadline
26 September 2025
Engagement process description
This contract comprises two distinct phases. For phase 1 the Authority wishes to purchase service to bring the CPRD Safe Trusted Research Environment system out of MVP into Alpha, Beta and production phases by continually developing the product using agile methodology. Phase 2 will focus on service and Maintenance of the CPRD Safe Trusted Research Environment system. MHRA is looking to award one contract to one supplier, but reserves the right to award more than one contract to more than one supplier.
For the avoidance of doubt, any information provided to the MHRA in response to this RFI will be treated as confidential and non-binding. No contract will be awarded as a consequence of this RFI process, however, the MHRA may launch a procurement opportunity in the near future.
Responding to this RFI is not a prerequisite for participation in a subsequent procurement, nor does it give any advantage in that procurement. The MHRA would welcome responses to this RFI in order that the MHRA can build an understanding regarding the current and future provision of the project.
For the avoidance of doubt, any information provided to the MHRA in response to this RFI will be treated as confidential and non-binding. No contract will be awarded as a consequence of this RFI process, however, the MHRA may launch a procurement opportunity in the near future.
Responding to this RFI is not a prerequisite for participation in a subsequent procurement, nor does it give any advantage in that procurement. The MHRA would welcome responses to this RFI in order that the MHRA can build an understanding regarding the current and future provision of the project.
The date by which responses to the RFI must be received is 14:00 on 26th September 2025.
For a copy of the RFI document, please email: jonathon.moloney@mhra.gov.uk and during the period 16th September - 26th September please email julieanne.mollen@mhra.gov.uk for a copy of the RFI document.
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
29 September 2025
Contracting authority
MHRA
- Public Procurement Organisation Number: PJLJ-9824-VXPG
10 South Colonnade, Canary Wharf
London
E14 4PU
United Kingdom
Contact name: Jonathon Moloney
Email: jonathon.moloney@mhra.gov.uk
Website: https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
Region: UKI42 - Tower Hamlets
Organisation type: Public authority - central government